Advisory Board and Editors Dermatology
Bruno Fionda
Dr. Fionda graduated in Medicine and Surgery and subsequently specialized in Radiotherapy at the Catholic University of the Sacred Heart in Rome. He started working in 2016 at Gemelli-ART (Advanced Radiation Therapy) in Rome dealing with special techniques, such as Surface Guided Radiotherapy (SGRT) which uses specific light sources to monitor the patient’s surface during therapy. Dr. Fionda worked with the first hybrid machine installed in Italy that combines modern linear accelerators (LINAC) with the acquisition of magnetic resonance images allowing to follow the movement of the internal organs in real time. He has also gained long experience in interventional radiotherapy (brachytherapy) with both high dose rate (HDR) and pulsed dose rate (PDR).
Dr Fionda is a member of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) and of the European Society for Radiotherapy and Oncology (ESTRO). He is the author of over 100 publications including conference abstracts and research articles on national and international journals, and is adjunct Professor of Radiation Oncology at Saint Camilus International University of Healh Sciences.
Victor J. Hruby
Regents Professor of Chemistry and Biochemistry at the University of Arizona. Professor of Neuroscience recently inducted into the ACS Hall of Fame and 2011 ACS Goodman Award for Scientific Excellence and Mentorship.
Ralf Paus
Professor Ralf Paus researches into the biology and pathology of the hair follicle, skin neuroendocrinology, and the science and applications of stem cells residing in human skin.
Mauro M.M. Picardo
Director of the Cutaneous Physiopathology Laboratory and Metabolomic Center San Gallicano Dermatological Institute in Rome
Chairman Integrated Center of Metabolomic Research
Member of Italian Commission for Dietetic and Nutrition at the Minister of Health (2006- present)
Member of National Health Council (2007-2010)
Member of the Psocare National Commission supported by the Italian Agency on Drugs (AIFA)
Past President of the European Society for Dermatological Research
Past President of the International Federation of Pigment Cell Societies (IFPCS)
Past President of the European Society of Pigment Cell Research (ESPCR)
Board member of the European Society for Dermatological Research (ESDR)
Member of the European Academy of Dermatology and Venereology (EADV)
Member of the Italian Society of Dermatology and Venereology (SIDEMAST)
Member of the Italian Association of Dermatolgists (ADOI)
Coordinator of the Vitiligo European Task Force
Associate Editor of Pigment Cell Research
Editorial board of PeerJ, Experimental Dermatology, Clinical and Experimental Dermatology
Referee ad hoc for many dermatological journals such as Journal of Investigative Dermatology, British Journal of Dermatology, Journal of EADV, Experimental dermatology, and non dermatological journals such as FASEB J, BBA, J Chromatography, Biochem J, PlOS ONE, Free radical in Biology and Medicine
Author of more than 250 publications and of more than 30 chapters in different books
Tarl W Prow
Dr. Tarl Prow is the Deputy Director of the Dermatology Research Centre within the School of Medicine and heads a group of 10 researchers focused on micromedical devices for dermatology and nanomedicine. He is a multidisciplinary researcher with internationally recognized expertise in the fields of micro-medical device development, nanodermatology, topical drug delivery and non-invasive imaging.
Mansour Sobeh
Mansour Sobeh holds a B.Sc. in Chemistry from Ain Shams University, Egypt, an M.Sc. in Analytical Chemistry from the German University in Cairo, Egypt, and a Ph.D. in Natural Sciences (Dr. rer. nat.) from Heidelberg University, Germany. He is currently an Assistant Professor at Mohammed VI Polytechnic University
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.
Desmond J Tobin
Desmond Tobin is Professor of Dermatological Science, and Director of the UCD Charles Institute of Dermatology, School of Medicine, University College Dublin, Ireland. EU. Prior he was Professor of Cell Biology & Director of the Centre for Skin Sciences at University of Bradford. He holds a BSc from the National University of Ireland (Maynooth), a PhD from University of London (St. John’s Institute of Dermatology) and post-doc training from New York University Medical School. Over 25y he has researched in basic and applied skin/hair sciences, with a particular focus on the biology of human melanocytes/ pigmentation and hair growth disorders incl. with immune basis.
He was the first to identify antibodies to hair follicle-specific antigens in patients with acute alopecia areata, and first to establish melanocytes from human hair follicles in long-term culture. He has identified a self-similarity of the POMC peptide system in human hair follicle pigmentary unit, how pigmentation can be regulated by CRF/POMC peptides (incl. b-endorphin), and more recently by bone morphogenetic proteins. He revealed an unexpected role for filopodia in melanin transfer under influence of myoxin-X & cdc42. Des is a Fellow of Royal College of Pathologists, Fellow of Royal Society of Biology, and Fellow of Institute of Trichologists (Vice-President), and Member of the Royal Irish Academy. Des serves(ed) on several editorial boards, and has published over 200 publications, incl. 3 books. His H-Index is currently 68 (Scopus).
Guangdong Yang
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 7,481 (September 24, 2018).